Neu3 - neuraminidase 3 Gene
Species: Rattus norvegicus
Summary
Predicted to enable exo-alpha-(2->3)-sialidase activity and exo-alpha-(2->8)-sialidase activity. Predicted to be involved in several processes, including ganglioside catabolic process; negative regulation of clathrin-dependent endocytosis; and positive regulation of epidermal growth factor receptor signaling pathway. Predicted to act upstream of or within carbohydrate metabolic process. Predicted to be located in bounding membrane of organelle and external side of plasma membrane. Predicted to be active in cytoplasm; intracellular membrane-bounded organelle; and membrane. Orthologous to human NEU3 (neuraminidase 3). [provided by Alliance of Genome Resources, Apr 2022]
Neu3 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001393673.1 | NP_001380602.1 | sialidase-3 |
| NM_054010.2 | NP_446462.1 | sialidase-3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
sialidase-3 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-125798 | 2,3-Dehydro-2-deoxy-N-acetylneuraminic acid | Inhibitor | ≥99.0% | Unkown |
| HY-161943 | NEU3-IN-1 | 99.78% | Unkown | |
| HY-RS09217 | NEU3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22252 | Neu3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28774 | Neu3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service